- cafead   Oct 25, 2023 at 09:42: AM
via AbbVie has announced a collaboration with Lupus Therapeutics to increase clinical trial recruitment activities in its systemic lupus erythematosus (SLE) trial.
The alliance is intended for the Phase III clinical programme of AbbVie’s upadacitinib (RINVOQ) in SLE patients.
article source
The alliance is intended for the Phase III clinical programme of AbbVie’s upadacitinib (RINVOQ) in SLE patients.
article source